StockData
agilon health, inc. logo

agilon health, inc. (AGL) stock

AGLNYSEServices-Misc Health & Allied Services, NECFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 4/30
$115.20−1.55 (-1.33%)

Close on Nov 17, 2026Market cap $1.93BP/E –Yield –

agilon health price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

agilon health's price to sales ratio was 0.3× on Nov 11, 2026, against 0.0× a year earlier. Over the last 5 years it ranged from 0.0× to 6.7×, with a median of 0.6×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20260.3×+0.3
2025Dec 31, 20250.0×−0.1
2024Dec 31, 20240.1×−1.3
2023Dec 29, 20231.4×−1.7
2022Dec 30, 20223.1×−3.2
2021Dec 31, 20216.2×–

More agilon health figures

See a number that looks wrong?